353.2500 -5.05 (-1.41%)
NSE Aug 28, 2025 15:31 PM
Volume: 2.5M
 

353.25
-1.41%
Axis Direct
Management indicated that R&D costs will increase in the upcoming quarters which may pose threat to the current margins of the company. We, therefore, recommend a HOLD rating on the stock with a TP of Rs 310/share.
Biocon Ltd. is trading above its 200 day SMA of 352.6
More from Biocon Ltd.
Recommended